Switzerland· 27620001
Gastrografin, Lösung zum Einnehmen / Rektallösung
A diatrizoic acid product, registered in Switzerland by Bayer (Schweiz) AG and dispensed under Swissmedic category B. The same ATC class is registered in 9 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Diatrizoic acid is registered in 9 of 19 countries.
Countries holding a registration under ATC V08AA01 (diatrizoic acid), each read from that country’s own register.
- This record: Switzerland
- 5 of them publish a price we can compare per daily dose
Diatrizoic acid · ATC V08AA01
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Bayer (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- V08AA01
- ATC class
- Diatrizoic acid
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V08AA01
Diatrizoic acid, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bac3958c-97c5-4ad5-910e-c2a1982d5d8c GET /v1/drugs/bac3958c-97c5-4ad5-910e-c2a1982d5d8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about diatrizoic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.